This group first established that in each case the adjacent, non-involved tissues had very high KDM5D expression compared to the tumor and found, through the examination of patient data in the GEO database, that severely lowered KDM5D expression in colorectal cancer was highly predictive of poor clinical outcome. This evidence concerns the gene KDM5D and colorectal cancer.